1. Home
  2. HNVR vs MOLN Comparison

HNVR vs MOLN Comparison

Compare HNVR & MOLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hanover Bancorp Inc.

HNVR

Hanover Bancorp Inc.

HOLD

Current Price

$21.70

Market Cap

153.5M

Sector

Finance

ML Signal

HOLD

Logo Molecular Partners AG

MOLN

Molecular Partners AG

HOLD

Current Price

$3.71

Market Cap

158.9M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
HNVR
MOLN
Founded
2008
2004
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Commercial Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
153.5M
158.9M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
HNVR
MOLN
Price
$21.70
$3.71
Analyst Decision
Buy
Buy
Analyst Count
2
2
Target Price
$24.50
$8.38
AVG Volume (30 Days)
4.7K
3.3K
Earning Date
04-22-2026
05-14-2026
Dividend Yield
1.87%
N/A
EPS Growth
N/A
N/A
EPS
1.00
N/A
Revenue
N/A
N/A
Revenue This Year
$35.49
N/A
Revenue Next Year
$8.61
$318.52
P/E Ratio
$21.59
N/A
Revenue Growth
N/A
N/A
52 Week Low
$18.31
$3.36
52 Week High
$24.36
$5.36

Technical Indicators

Market Signals
Indicator
HNVR
MOLN
Relative Strength Index (RSI) 53.50 37.68
Support Level $21.60 $4.04
Resistance Level $22.41 $4.63
Average True Range (ATR) 0.50 0.24
MACD 0.13 -0.07
Stochastic Oscillator 49.24 27.69

Price Performance

Historical Comparison
HNVR
MOLN

About HNVR Hanover Bancorp Inc.

Hanover Bancorp Inc is a community commercial bank focused on providing personalized and efficient services and products tailored to local needs. The Bank offers a full range of financial services, including a complete suite of consumer, commercial, and municipal banking products such as multifamily and commercial mortgages, government-guaranteed loans, residential loans, business loans, and lines of credit. In addition, it provides customers with access to 24-hour ATM services with no fees, interest-bearing free checking accounts, telephone banking, mobile and internet banking solutions for both consumer and business clients, and safe deposit boxes.

About MOLN Molecular Partners AG

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.

Share on Social Networks: